Navigation Links
New insight into protein misfolding in neurodegenerative disorders
Date:2/14/2014

Research by the University of Southampton has provided new insight into the consequence of accumulated 'misfolded proteins' in neurodegenerative disorders, such as Prion and Alzheimer's disease.

Prion and Alzheimer's disease are protein misfolding brain diseases, where genetic mutations, or more commonly, interactions between an individual's genetics and environmental influences cause functional proteins in neurons to become misfolded or misrouted. In these diseases, there is a progressive death of nerve cells in specific brain regions, which is associated with the increasing extracellular or intracellular accumulation of misfolded proteins. This leads to synapse degeneration and eventual loss of nerve cells and cognitive and behavioural conditions associated with the disease.

To increase the understanding of the disease mechanisms, the researchers, led by Dr Ayodeji Asuni from the University's Centre for Biological Sciences, compared prion disease brain tissue, which mirrors key features of Alzheimer's disease, and the brain of control mice.

They found that the degenerative process is paralleled by an increase in astrocytes a major support cell in the brain and four specific astrocytes-associated proteins: GFAP (structural protein), peroxiredoxin-6 (an antioxidant protein), EAAT-2 (glutamate transporter), and Clusterin (a chaperone protein). These are produced in greater amounts in response to the misfolding protein, perhaps to provide support and protection for neurons in the brain.

Current research has identified Clusterin as a biomarker for Alzheimer's disease and Dr Asuni's team extended their investigation to address whether Clusterin changes in the brain could be detected in the blood; such a result would have confirmed Clusterin as a potential biomarker for brain disease.

Dr Asuni says: "In contrast to observations made in Alzheimer's disease, the increased Clusterin expression in the brain was not reflected in the circulating levels of Clusterin in late-stage prion disease.

"So we caution against the assumption that plasma levels of Clusterin provide an alternate peripheral measure for the progression of brain degeneration. We believe the observations from our study in experimental conditions, in which potential confounds can be well controlled, will likely be of value in the interpretation of results from Alzheimer's disease patients."


'/>"/>

Contact: Glenn Harris
G.Harris@soton.ac.uk
44-023-805-93212
University of Southampton
Source:Eurekalert  

Related biology news :

1. New insight into an emerging genome-editing tool
2. Paper offers insights into network that plays crucial role in cell function and disease
3. Gene that influences receptive joint attention in chimpanzees gives insight into autism
4. Zebra fish fins help Oregon researchers gain insight into bone regeneration
5. Scripps Florida scientists offer new insight into neuron changes brought about by aging
6. New insights into facial transplantation
7. Elephant shark genome provides new insights into bone formation and adaptive immunity in humans
8. New research provides insight into epilepsy
9. The origin of flowers: DNA of storied plant provides insight into the evolution of flowering plants
10. Study led by NUS scientists provides new insights into cause of human neurodegenerative disease
11. Oregon scientists offer new insights on controlling nanoparticle stability
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New insight into protein misfolding in neurodegenerative disorders
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 2017  Driven by consumers, preference towards more ... fastest growing categories, finds the recently published U.S. ... Care: Multi-regional Market Analysis and Opportunities study ... Kline. "Biotechnology actives are derived from ... effective for skin and hair care applications," explains ...
(Date:2/24/2017)... 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a ... Key Opinion Leader event to highlight new clinical data ... presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and ... be held in-person and via live webcast on Tuesday, ... PST at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
Breaking Biology Technology: